Blue Cap AG, a Munich-based investment company, has announced a significant change to its Management Board. Dr. Henning von Kottwitz, Chairman of the Management Board, will leave the company effective at the end of October 8, 2026, by mutual agreement with the Supervisory Board. The Supervisory Board expressed its gratitude for his service and commitment, noting that Blue Cap AG is well positioned for further development, particularly due to transactions implemented in recent years under his leadership.
In a related move, the Supervisory Board has resolved to second its Chairman, Dr. Christian Diekmann, to the Management Board as a member effective October 9, 2026, pursuant to Section 105(2) of the German Stock Corporation Act (AktG). Dr. Diekmann will be responsible for strategy and finance. Henning Eschweiler will remain a member of the Management Board as COO, continuing to oversee operational portfolio management, and will additionally assume responsibility for M&A starting October 9, 2026. Dr. Diekmann has served as Chairman of Blue Cap AG's Supervisory Board since 2024 and brings extensive experience in operational restructuring and management of medium-sized corporate groups, having previously served as CEO of Max Automation SE and CFO of Zertus Group.
Dr. Michael Schieble, Deputy Chairman of the Supervisory Board, commented, “We are very pleased that Dr. Christian Diekmann has agreed to drive the further development of Blue Cap AG’s business model as a member of the Management Board in the near term and take it to the next level. As Chairman of the Supervisory Board, he has in-depth knowledge of Blue Cap and understands its potential as a listed investment company pursuing the successful Buy-Transform-Sell strategy.” Dr. Diekmann added, “Blue Cap AG is ideally positioned as an investor in ‘special situations’ to grow in the current economic environment. Many companies that are fundamentally well positioned for the future are increasingly affected by disruptions in industry and structural challenges. We aim to address these challenges through our business model, strengthen Germany as an industrial location and create value for our shareholders. In my new role, I look forward to working even more closely with Blue Cap AG’s highly qualified team.”
The leadership transition comes at a time when Blue Cap AG continues to execute its Buy-Transform-Sell strategy, focusing on medium-sized B2B companies in special situations. The company currently holds majority stakes in six portfolio companies operating in plastics engineering, production engineering, pre-press solutions, life sciences, and business services, employing around 2,000 people across Germany, Europe, North America, and Asia. The appointment of Dr. Diekmann, with his deep understanding of the company and extensive operational and financial expertise, is expected to ensure continuity and drive further growth. As a listed investment company, Blue Cap AG’s shares trade on the Open Market (Scale, Frankfurt, and m:access, Munich; ISIN: DE000A0JM2M1; ticker symbol: B7E). Further details about the company can be found at www.blue-cap.de. The original release is available on www.newmediawire.com.
The changes highlight Blue Cap AG’s commitment to strong leadership and strategic alignment as it navigates a challenging economic landscape. With Dr. Diekmann at the helm of the Management Board, alongside Mr. Eschweiler, the company aims to strengthen its position as an investor in special situations and create long-term value for shareholders.
